BioSpace News Archive

Nines announced the 510(k) FDA clearance for NinesMeasure™, an innovative lung nodule measurement tool built with artificial intelligence (AI) that can accelerate diagnoses of certain respiratory diseases.

Janux Therapeutics, a biopharmaceutical company developing novel T cell engager immunotherapies, today announced the appointment of Charles Winter as Senior Vice President of Chemistry, Manufacturing, and Controls (CMC)

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics today announced the Denver Business Journal has recognized Zynex as the sixth largest Biotechnology/Bioscience public company

Alpha II, LLC, a leading provider of software-as-a-service solutions focused on improved revenue cycle performance for both ambulatory and acute care providers, announces an update to their E&M Generate™ solution to include the revised 2021 office and outpatient evaluation and management guideline updates.

Canada’s universal, publicly funded health care system is a source of pride for Canadians.

Webster Dental Care, an industry leading dental service organization with eleven locations, announces the addition of Dr. Brandon Becker to its expert team.

The Government of Canada is committed to reducing the spread of COVID-19 and the variants of concern in Canada. Self-isolation is one of the most effective ways to help stop the spread of COVID-19.

AVITA Medical, Inc., a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced that 15 abstracts highlighting the clinical and cost-savings benefits of the RECELL® Autologous Cell Harvesting Device have been accepted at the American Burn Association 53rd Annual Meeting.

Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that its management team will present at the 20th Annual Needham Virtual Healthcare Conference on Tuesday, April 13, 2021 at 3:45 p.m. Eastern Time.

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, today announced its 2021 clinical plans and reported financial results for the fourth quarter and year ended December 31, 2020.